Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 04, 2026

Hexcel Corporation (HXL): Navigating Recent -14% Pullback Amid Aerospace Recovery Signals

Key Takeaways

  • HXL stock declined approximately -14% over the past 30 days amid profit-taking after a peak near $95, ongoing aerospace supply chain disruptions, and a CFO transition announcement.
  • Over the past quarter, the stock rose about +3%, driven by strong Q4 2025 earnings beat, positive 2026 guidance, and analyst upgrades reflecting commercial aerospace recovery.
  • Key drivers include robust demand for lightweight composites in commercial aerospace and defense, tempered by production delays on programs like Airbus A350 and channel destocking.
  • Recent analyst actions, such as upgrades from Morgan Stanley and BofA, supported earlier gains, while sector-wide supply chain issues contributed to the recent pullback.
  • Hexcel's 2026 outlook projects 8% sales growth and 25% adjusted EPS expansion, signaling operating leverage from rising aircraft build rates.

Understanding Hexcel Corporation (HXL) and Its Market Position

Hexcel Corporation stands out as a leading developer and manufacturer of advanced lightweight composites, including carbon fiber reinforcements, resin systems, honeycomb, and engineered products. The company operates in two main segments: Composite Materials and Engineered Products, serving commercial aerospace, defense and space, and industrial markets such as high-performance automotive.

In my view, Hexcel holds a strong competitive position as the world leader in honeycomb manufacturing for commercial aerospace, with materials used on virtually every commercial and military aircraft. Its business model centers on high-value, lightweight solutions that enhance fuel efficiency and performance, which ties it closely to aircraft production cycles. This explains the recent stock behavior: gains from recovering demand post-destocking, but volatility from OEM production delays.

HXL Stock Performance: The Last 30 Days Versus the Quarter

Over the last 30 days, HXL stock fell from around $92 on March 3 to $79.21 as of April 2, a decline of approximately -14%. The movement was volatile, peaking at $94.73 on March 2 before a steady pullback to a low near $77 in late March, with a partial recovery in early April. This range-bound yet downward trend reflects sector pressures outweighing positive fundamentals.

For the past quarter, the stock advanced from about $77 in early January to $79.21, up roughly +3%. It exhibited a trend-driven rise to the early March high, followed by correction, amid broader market and industry dynamics. The 50-day moving average stands at $85.01, above the current price, indicating short-term weakness, while the 200-day moving average at $71.27 supports longer-term uptrend. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Factors Behind HXL's 30-Day Decline

The 30-day decline stemmed primarily from profit-taking after the stock's all-time high near $95 in early March, exacerbated by aerospace supply chain disruptions delaying aircraft production ramps, particularly on the Airbus A350 program. Channel destocking persisted, pressuring near-term sales and margins.

A key company-specific event was the March 13 announcement naming James Coogan as the new CFO effective May 1, coinciding with a sharp drop and contributing to a 9-day losing streak of -17% at one point, as investors assessed leadership transition risks. Sector news, including labor shortages and slower OEM build rates, added downward pressure despite positive long-term demand.

These factors overshadowed stabilizing trends like abating destocking, leading to heightened volatility and a net price retreat. From what I see, this pullback has created a potential entry point for those focused on the longer-term story.

What Propelled HXL Over the Past Quarter

The quarterly uptrend was propelled by Hexcel's Q4 2025 earnings release on January 29, which beat expectations with $491.3 million in sales (up 3.7% year-over-year) and adjusted EPS of $0.52, alongside full-year free cash flow of $157 million and a 6% dividend hike to $0.18 per share. Upbeat 2026 guidance—sales of $2.0-$2.1 billion and adjusted EPS of $2.10-$2.30—highlighted expected operating leverage from commercial aerospace recovery.

Analyst upgrades fueled momentum: Morgan Stanley to Equal-Weight ($90 target) and BofA to Neutral ($95 target) in late January/early February, citing fading destocking and widebody recovery. Rising defense and space spending, plus partnerships like the Dassault Falcon 10X rollout, bolstered sentiment. Macro tailwinds included increasing aircraft backlogs, though partially offset by supply chain hurdles.

Discovering Trending AI Robots for Your Trading

In my own research process, I often turn to Tickeron’s Trending AI Robots page, which showcases the platform's top-performing AI trading bots from among hundreds that trade thousands of tickers across various markets. These curated bots are selected based on recent performance metrics, relevance to current market trends, and strategy effectiveness. Strategies range from momentum and mean reversion to pattern recognition, spanning short-term day trades to longer-term swings, with transparency on win rates, average returns, and drawdowns. This resource has helped me discover automated tools tailored to my risk tolerance and timeframe, enhancing my analysis of stocks like HXL.

HXL Forecast: What I'm Watching Next

One thing that stands out is the upcoming Q1 2026 earnings release on April 22 and conference call on April 23—I'm watching these closely for updates on sales execution, margin trends, and progress against 2026 guidance amid aircraft production ramps.

Key industry trends include Airbus and Boeing build rates, especially A350 recovery, and defense spending amid geopolitical tensions. Macro factors like supply chain stabilization, inflation, labor availability, and interest rates could sway demand for composites.

Strategic developments, such as the new CFO's impact on capital allocation and share repurchases, plus partnerships in commercial and space sectors, warrant attention. Risks include prolonged destocking or regulatory hurdles for OEMs (original equipment manufacturers), while catalysts may arise from accelerated production or M&A (mergers and acquisitions) activity. This is important because it could determine whether the recent pullback marks a buying opportunity.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: HXL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


HXL in -4.02% downward trend, declining for three consecutive days on August 21, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HXL declined for three days, in of 271 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HXL as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HXL turned negative on July 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

HXL moved below its 50-day moving average on August 19, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HXL crossed bearishly below the 50-day moving average on August 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HXL advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

HXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 252 cases where HXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HXL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.467) is normal, around the industry mean (7.037). P/E Ratio (47.404) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (1.295) is also within normal values, averaging (8.077). Dividend Yield (0.008) settles around the average of (0.017) among similar stocks. P/S Ratio (3.689) is also within normal values, averaging (20.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
HXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of lightweight composites

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
281 Tresser Boulevard
Phone
+1 203 969-0666
Employees
5590
Web
https://www.hexcel.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Hexcel Corporation (HXL): Navigating Recent -14% Pullback Amid Aerospace Recovery Signals